Genolution Inc. (KOSDAQ:225220)

Genolution Statistics

Total Valuation

Genolution has a market cap or net worth of KRW 40.47 billion. The enterprise value is 33.97 billion.

Market Cap	40.47B
Enterprise Value	33.97B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genolution has 18.07 million shares outstanding. The number of shares has decreased by -0.68% in one year.

Current Share Class	18.07M
Shares Outstanding	18.07M
Shares Change (YoY)	-0.68%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	13.81%
Owned by Institutions (%)	0.02%
Float	12.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.62
PB Ratio	0.54
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.31
EV / Sales	3.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.15

Financial Position

The company has a current ratio of 5.90, with a Debt / Equity ratio of 0.32.

Current Ratio	5.90
Quick Ratio	5.26
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-2.24
Interest Coverage	-10.25

Financial Efficiency

Return on equity (ROE) is -13.54% and return on invested capital (ROIC) is -5.24%.

Return on Equity (ROE)	-13.54%
Return on Assets (ROA)	-5.12%
Return on Invested Capital (ROIC)	-5.24%
Return on Capital Employed (ROCE)	-9.24%
Revenue Per Employee	116.90M
Profits Per Employee	-136.76M
Employee Count	75
Asset Turnover	0.08
Inventory Turnover	2.05

Taxes

Income Tax	-564.23M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.45% in the last 52 weeks. The beta is -0.01, so Genolution's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-24.45%
50-Day Moving Average	2,374.90
200-Day Moving Average	2,391.78
Relative Strength Index (RSI)	44.06
Average Volume (20 Days)	66,924

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genolution had revenue of KRW 8.77 billion and -10.26 billion in losses. Loss per share was -568.01.

Revenue	8.77B
Gross Profit	3.85B
Operating Income	-8.76B
Pretax Income	-11.43B
Net Income	-10.26B
EBITDA	-6.39B
EBIT	-8.76B
Loss Per Share	-568.01

Balance Sheet

The company has 30.69 billion in cash and 24.15 billion in debt, giving a net cash position of 6.53 billion or 361.58 per share.

Cash & Cash Equivalents	30.69B
Total Debt	24.15B
Net Cash	6.53B
Net Cash Per Share	361.58
Equity (Book Value)	74.65B
Book Value Per Share	4,130.13
Working Capital	29.92B

Cash Flow

In the last 12 months, operating cash flow was -6.75 billion and capital expenditures -4.04 billion, giving a free cash flow of -10.78 billion.

Operating Cash Flow	-6.75B
Capital Expenditures	-4.04B
Free Cash Flow	-10.78B
FCF Per Share	-596.93

Margins

Gross margin is 43.94%, with operating and profit margins of -99.87% and -116.99%.

Gross Margin	43.94%
Operating Margin	-99.87%
Pretax Margin	-130.34%
Profit Margin	-116.99%
EBITDA Margin	-72.87%
EBIT Margin	-99.87%
FCF Margin	n/a

Dividends & Yields

Genolution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.68%
Shareholder Yield	0.68%
Earnings Yield	-25.34%
FCF Yield	-26.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.

Last Split Date	Apr 19, 2023
Split Type	Forward
Split Ratio	2

Scores

Genolution has an Altman Z-Score of 2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	3